2018
DOI: 10.1177/0268355518802693
|View full text |Cite
|
Sign up to set email alerts
|

Thrombophilic risk factors are laterally associated with Apolipoprotein E gene polymorphisms in deep vein thrombosis patients: An Indian study

Abstract: Introduction Deep vein thrombosis is a multifactorial disease with many acquired and genetic risk factors. Polymorphism in the APOE gene is an upcoming potential pathogenic factor whose role is unclear in deep vein thrombosis. Methods An equal number of deep vein thrombosis cases and controls (N = 100, each) were investigated for APOE gene polymorphisms along with known acquired and hereditable thrombophilic risk factors. APOE genotyping was done by polymerase chain reaction. Results The ε3/ε4 and ε2/ε3 APOE g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…129 In contrast, other studies did not find any significant associations. 130,131 ADAMTS13 ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a plasma glycoprotein that regulates the size distribution of vWF. 132 Due to the presence of uncleaved, ultra-large vWF multimers, severe lack of ADAMTS13 activity leads to thrombocytopenic purpura, a specific type of thrombotic microangiopathy.…”
Section: Apolipoprotein Ementioning
confidence: 99%
“…129 In contrast, other studies did not find any significant associations. 130,131 ADAMTS13 ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a plasma glycoprotein that regulates the size distribution of vWF. 132 Due to the presence of uncleaved, ultra-large vWF multimers, severe lack of ADAMTS13 activity leads to thrombocytopenic purpura, a specific type of thrombotic microangiopathy.…”
Section: Apolipoprotein Ementioning
confidence: 99%